Surgery followed by ipilimumab treatment in melanoma patients improves survival, say researchers

A study has demonstrated that a drug called ipilimumab improves the relapse-free survival of advanced stage melanoma patients rendered free of disease surgically but at high risk for relapse. Ipilimumab is approved for the treatment of melanoma that cannot be surgically removed or that has metastasized to different sites. —> Read More